-
Miranda Lambert Leads North Texans with Seven Grammy Nominations for 2027
-
DiDi Advances Robotaxi Operations in China with New R2 Vehicle and Expanded Safety Infrastructure
-
Smart Car Seats Tested: Do Sensors and Apps Actually Improve Safety?
-
XPENG Launches Two New Models in UK; Pony.ai Robotaxi Enters Pilot
-
RuffleButts + RuggedButts Featured in Hasbro's 2026 Holiday Gift Guide
-
Dermata Highlights Additional Results and Photos from Cosmetic Study Evaluating Its Tome Foundational Treatment
-
NexCore and MetLife Investment Management Launch $1.3 Billion Senior Living Co-Investment Venture
-
Tectonic Metals Completes Record Drill Program at Flat, Advances Five Pillars of Growth Toward Major 2027 Milestones
-
Glidewell Opens Applications for 2027 Guiding Leaders Cohorts in California and North Carolina
-
International Business Times UK Increases Programmatic Revenue by 30% with Opti Digital
-
Valion Bio Reports Completion of 200-Liter Entolimod Production Run; Material Supplying Ongoing AFRRI Study
-
Miami Allstars FC have Applied to Compete in the Women's Premier Soccer League, with the Club Targeting a 2027 or 2028 Debut in North Miami, Florida
-
Klique Joins Lenovo AI Innovators, Bringing Its Enterprise AI Control Plane to Lenovo Hybrid AI Factory
-
Waste Energy to Host Shareholder Update Today at 4:30 PM EST; Management to Discuss WE #1 Commissioning, Revenue Opportunities and Growth Strategy
-
FaZe Esports, a GameSquare Company, Wins Rainbow Six Championship at Osaka Major
-
Pinnacle Food Group Limited Achieves Laboratory-Scale Astaxanthin Extraction in Haematococcus pluvialis Program
-
BioLargo Reports Third Quarter 2026 Results, Forecasting Commercial Breakout in 2027
-
Viking Global Technologies Announces Expansion of Grid Protection Technology Pilot with Another Major U.S. Electric Utility
-
Nexscient Reports Third Quarter 2026 Results; Revenue Rises Sequentially as Gross Margin Expands to Over 40%
-
TRNR Reports Record Q3 2026 Results, Driven by 66% Revenue Growth; M&A Pipeline Grows Significantly
-
Ur-Energy Commences Baseline Study Fieldwork; Nears Completion of Technical Report at Lost Soldier Uranium Project, Wyoming
-
How to Turn Your Garage into Usable Living Space
-
Pilot-Founded Solara Global Jet Offers Charter, Leases and Air Cargo Nationwide and Overseas
-
Driving Global Innovation - GTDC Summit APJ Underscores Distribution's Transformative Power
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 17
-
PRAAMS AI Co-Investor Now Covers 400,000+ Global Instruments, With Responses From 3 Seconds, Cost From US$0.01, and Scalability to Millions of Users
-
Broad Clinical Labs Drives Strong Digital Engagement by Connecting Customers with Published Research Through Bioz
-
Razavi Law Group Partners with Chapman University to Prepare the Next Generation of Attorneys
-
ImageWorks Display Advances Whole-Store Solutions with a Re-Imagined Planniq Strong and Planniq Chill
-
KIDZ AI Announces Strategic Collaboration with Synestria to Optimize AI Infrastructure Performance
-
Pivotree Announces Third Quarter 2026 Results
-
MedMira Receives U.S. FDA Breakthrough Device Designation for Its Multiplo(R) Complete Syphilis (TP/nTP) Antibody Test
-
Gabriel Resources Provides Corporate and Financing Update
-
HippoFi Achieves OTCID Market Designation, Opening a New Chapter of Commercial Growth
-
Galway Metals Intersects 1.8 g/t Gold Over 25.0 Metres and 0.7 g/t Gold Over 66.0 Metres at Clarence Stream
-
Avino Announces Key Technical Appointment
-
Brightline Interactive and TruWeather Solutions Sign MOU to Bring Weather Data into SpatialCore Physical AI Platform
-
Can Your Trash Can Pass the Holiday 'Eww' Test?
-
RMTG Expands Cellular Hope Institute's Cancún Clinical Facilities and Longevity Platform
-
Platinum Deck and Patio Announces Nashville, Tennessee Launch
-
Wedgewood Weddings Brings Creekside Mountain Celebrations to Idaho Springs with Blackstone Rivers
-
LIBRA Insurance Partners Welcomes Trawick Financial Services to Its Partner Network
-
FibreSeek Expands U.S. Availability of FibreSeeker 3 with Local Stock and Fulfillment
-
DASI Simulations Named to the 2026 CB Insights' 50 Most Promising Digital Health Startups
-
Islo Secures $15 Million Investment Led by Insight Partners to Scale Enterprise Software Factory Platform
-
Bluedrop Medical Appoints Mark Grant as CEO to Advance Commercialization and Strategic Growth
-
Join Nord Precious Metals' Live Investor Webinar: Advancing Silver Production and High-Grade Exploration in Ontario
-
Who Is the Best Plastic Surgeon in the Pacific Northwest?
-
BHG Financial Closes a New ABS Transaction of $495 Million
-
Spider Labs Upgrades YouTube Placement Exclusions in Spider AF
Massachusetts Cannabis Contamination Crisis Exposes Federal Negligence While DEA Targets Science, Not Safety
Where Is the DEA? The Real Threat Isn't Research-It's Rotten Weed.
"This is the height of hypocrisy," said Duane Boise, CEO MMJ. "DEA bureaucrats are blocking clean cannabis grown in a DEA inspected cultivation facility, while contaminated products circulate freely under their watch. The agency has abandoned its duty to protect patients."
WASHINGTON, DC / ACCESS Newswire / August 7, 2025 / While the Massachusetts Cannabis Control Commission scrambles to contain a major public health scandal involving 544 contaminated marijuana samples, Thomas Prevoznik and the Drug Enforcement Administration (DEA)-the agency that claims to "protect public health and safety from the dangers of drugs"-is nowhere to be found.

According to a Public Health and Safety Advisory issued today by the Massachusetts Commission, contaminated and potentially contaminated marijuana products were sold throughout the state between April 1, 2024, and April 15, 2025. The issue? The products failed Total Yeast and Mold testing -a serious risk to patients and consumers, especially those who are immunocompromised. Yet this failure of regulatory oversight occurred right under DEA's nose, in a federally illegal marketplace they claim to police.
So, we ask again: Where is the DEA?
Moldy Marijuana, Real Harm
Massachusetts authorities have confirmed that hundreds of samples tested positive for contaminants but were somehow allowed to enter commercial circulation. This isn't about labeling violations or clerical errors-it's about inhaled mold, a known trigger for respiratory infections, allergic reactions, and even long-term lung damage.
The contaminated products were tracked using Metrc, a seed-to-sale traceability system required by law. The system worked. But what failed? Federal oversight, accountability, and DEA enforcement.
DEA Targets Science, Not Safety
While moldy weed was being sold to unsuspecting patients, what was the DEA doing?
Blocking MMJ BioPharma Cultivation from producing pharmaceutical grade cannabis for FDA approved clinical trials.
Sabotaging medical marijuana research with unconstitutional Administrative Law Judge (ALJ) proceedings.
Wasting time litigating against compliant, registered entities seeking to cure Huntington's Disease and Multiple Sclerosis.
Upholding a hypocritical regime where unregulated street level weed flourishes, while federally compliant applicants like MMJ BioPharma Cultrivation are stonewalled for trying to protect patients and follow science.
Let's be clear: the DEA is not protecting public health. It's obstructing it.
The Real Threat Isn't Research-It's Rotten Weed
The DEA's warped priorities are now a matter of public danger. Instead of helping to build a controlled, pharmaceutical-grade cannabis pipeline, the agency enables a fragmented, state-by-state chaos where contaminated products slip through the cracks and patients pay the price.
Ironically, the same agency that refuses to allow MMJ to grow clean, pharmaceutical cannabis in a DEA inspected facility also looks the other way as moldy, hazardous marijuana circulates in retail dispensaries.
MMJ BioPharma: Compliant, Blocked, and Ignored
MMJ BioPharma has:
secured a DEA analytical lab registration since 2022.
Submitted applications to manufacture and grow cannabis under Schedule I for FDA clinical trials.
Secured Orphan Drug Designation from the FDA for two devastating conditions.
And yet- after seven years -no federal approval.
A Simple Question for Administrator Terry Cole
Now that the Senate has confirmed Terry Cole as DEA Administrator, the public deserves an answer:
Will you keep blocking clean, FDA-regulated cannabis research while patients unknowingly inhale moldy weed from state markets you refuse to regulate?
The answer to that question will define not only your legacy-but whether the DEA finally chooses science over sabotage.
Final Thoughts
The DEA says it exists to fight drug abuse and protect public health. But in the face of real harm- contaminated marijuana entering legal markets -it's missing in action.
It's time for a new era of leadership. One where medical science leads, and moldy lies die.
The time for excuses is over. The time for action is now.
MMJ is represented by attorney Megan Sheehan.
CONTACT:
Madison Hisey
[email protected]
203-231-85832
SOURCE: MMJ International Holdings
View the original press release on ACCESS Newswire
A.Ruiz--AT